TLC BIOPHARMACEUTICALS INC;TAIWAN LIPOSOME COMPANY LTD
发明人:
HONG KEELUNG,GUO LUKE S.S.,SHIH SHEUE-FANG,CHANG PO-CHUN,TSAI CHIH-CHIANG,LIN HONG-HUI,TSENG YUN-LONG
申请号：
NZ62812413
公开号：
NZ628124A
申请日:
2013.02.08
申请国别(地区):
NZ
年份:
2016
代理人:
摘要：
The disclosure relates to pharmaceutical compositions comprising a combination of a lipid cake mixture comprising one or more phospholipids, with or without cholesterol, and a steroid solution comprising an ocular steroid preferably dexamethasone sodium phosphate, derivative thereof, a pharmaceutically acceptable salt thereof or a prodrug thereof, wherein the total amount of the phospholipid in the said composition is about 0.1 umol to less than about 2.5umol per 50ul of pharmaceutical composition and the side effects of the ocular steroid are reduced. The pharmaceutical composition is preferably administered by ocular route to treat ophthalmic diseases.
